TriVascular Receives U.S. FDA Approval
TriVascular, Inc. today announced the Premarket Approval (PMA) of the Ovation Abdominal Stent Graft System by the U.S. Food and Drug Administration (FDA) for the treatment of abdominal aortic aneurysms (AAA).
Comments are closed.
© 2016 Pinnacle Ventures. All Rights Reserved. |